Kodiak Sciences Inc.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
KOD$107.10+7.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Net Loss Per Common Share
- Net Loss per Common Share
The following common share equivalents were excluded from the computation of diluted net loss per common share for the periods presented because their inclusion would have been antidilutive:
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Outstanding stock options | 22,016,507 | 19,710,420 |
| Unvested restricted shares | 138,451 | 133,253 |
| ESPP | 38,203 | 50,248 |
| Total | 22,193,161 | 19,893,921 |
Item 2. Management’s Discussion and Analysis of
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.